Alliance Pharma plc

AIM:APH 株式レポート

時価総額：UK£243.5m

Alliance Pharma マネジメント

マネジメント 基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Nick Sedgwick

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間less than a year
CEOの所有権n/a
経営陣の平均在職期間7.2yrs
取締役会の平均在任期間less than a year

経営陣の近況

Recent updates

Investors Aren't Entirely Convinced By Alliance Pharma plc's (LON:APH) Revenues

Sep 10
Investors Aren't Entirely Convinced By Alliance Pharma plc's (LON:APH) Revenues

Is Alliance Pharma (LON:APH) A Risky Investment?

Jun 21
Is Alliance Pharma (LON:APH) A Risky Investment?

Not Many Are Piling Into Alliance Pharma plc (LON:APH) Just Yet

Feb 23
Not Many Are Piling Into Alliance Pharma plc (LON:APH) Just Yet

Estimating The Intrinsic Value Of Alliance Pharma plc (LON:APH)

Nov 21
Estimating The Intrinsic Value Of Alliance Pharma plc (LON:APH)

We Think Alliance Pharma (LON:APH) Is Taking Some Risk With Its Debt

May 26
We Think Alliance Pharma (LON:APH) Is Taking Some Risk With Its Debt

Alliance Pharma plc Just Missed Earnings - But Analysts Have Updated Their Models

Mar 24
Alliance Pharma plc Just Missed Earnings - But Analysts Have Updated Their Models

We Think Alliance Pharma (LON:APH) Can Stay On Top Of Its Debt

Sep 30
We Think Alliance Pharma (LON:APH) Can Stay On Top Of Its Debt

An Intrinsic Calculation For Alliance Pharma plc (LON:APH) Suggests It's 41% Undervalued

May 28
An Intrinsic Calculation For Alliance Pharma plc (LON:APH) Suggests It's 41% Undervalued

Alliance Pharma (LON:APH) Has A Pretty Healthy Balance Sheet

Mar 30
Alliance Pharma (LON:APH) Has A Pretty Healthy Balance Sheet

Did Alliance Pharma's (LON:APH) Share Price Deserve to Gain 81%?

Dec 24
Did Alliance Pharma's (LON:APH) Share Price Deserve to Gain 81%?

Do Fundamentals Have Any Role To Play In Driving Alliance Pharma plc's (LON:APH) Stock Up Recently?

Nov 19
Do Fundamentals Have Any Role To Play In Driving Alliance Pharma plc's (LON:APH) Stock Up Recently?

CEO（最高経営責任者

Nick Sedgwick (52 yo)

less than a year

在職期間

Mr. Nicholas John Sedgwick, also known as Nick, is Chief Executive Officer and Director of Alliance Pharma plc from May 13, 2024. Sedgwick brings thirty years of consumer health experience across European,...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Andrew Franklin
CFO & Executive Director9.2yrsUK£310.18k0.036%
£ 86.9k
Nicholas Sedgwick
CEO & Directorless than a yearデータなしデータなし
Stephen Kidner
Chief Scientific Affairs Officerno dataデータなしデータなし
Cora McCallum
Head of Investor Relations & Corporate Communicationsno dataデータなしデータなし
Christodoulos Chrysanthou
Group General Counsel & Company Secretary7.2yrsデータなしデータなし
Alex Duggan
Chief Commercial & Corporate Development Officerno dataデータなしデータなし
Julie Skinner
Chief People Officer1.8yrsデータなしデータなし
Chris Delafield
Global Marketing Head of Kelo-Cote7.8yrsデータなしデータなし
Rhodri Smith
Head of Sourcingno dataデータなしデータなし

7.2yrs

平均在職期間

経験豊富な経営陣: APHの経営陣は経験豊富で経験豊富です（平均在職期間は7.2年）。

取締役

名称ポジション在職期間報酬所有権
Andrew Franklin
CFO & Executive Director9.2yrsUK£310.18k0.036%
£ 86.9k
Nicholas Sedgwick
CEO & Directorless than a yearデータなしデータなし
Martin Sutherland
Independent Non-Executive Director1.8yrsUK£48.22kデータなし
Richard Crispin Jones
Senior Independent Non-Executive Director5.8yrsUK£58.84k0.013%
£ 30.6k
Camillo Pane
Independent Non Executive Chairless than a yearデータなしデータなし
Kristof Neirynck
Independent Non-Executive Director2.9yrsUK£52.80kデータなし
Richard McKenzie
Independent Non-Executive Directorless than a yearUK£7.27kデータなし
Eva-Lotta Sjostedt
Independent Non-Executive Directorless than a yearUK£7.27kデータなし
Martin Camilo
Member of Supervisory Boardless than a yearデータなしデータなし

1.0yrs

平均在職期間

55yo

平均年齢

経験豊富なボード: APHの 取締役会 は 経験豊富 ではない ( 1年の平均在任期間) ため、新しい取締役会が必要であると考えられます。